Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Burden and Outcomes of Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections (MBI-LCBI) in the First 100 Days after Allogeneic Stem Cell Transplant: A CIBMTR Analysis

Christopher E Dandoy, MD MS, Min Chen, MS, Soyoung Kim, Krishna Komanduri, MD, Caroline A. Lindemans, MD, Miguel-Angel Perales, MD, Marcie L. Riches, MDMS

Blood (2018) 132 (Supplement 1): 3375.

https://doi.org/10.1182/blood-2018-99-114629

Published: 2018

Journal Articles

Transplant Associated Thrombotic Microangiopathy in Individuals with Fanconi Anemia

Kasiani C. Myers, MD, Sonata Jodele, MD, Adam S. Nelson, MBBS, Erica Goodridge, Parinda A Mehta, MD, Robin Mueller, Christopher E. Dandoy, MD, Adam Lane, PhD, Javier A. El-Bietar, MD, Stella M Davies, MBBS, PhD

Blood (2016) 128 (22): 2217.

https://doi.org/10.1182/blood.V128.22.2217.2217

Published: 2016

Journal Articles

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Thomas Luft, MD PhD, Axel Benner, Sonata Jodele, MD, Christopher E. Dandoy, MD, Rainer F. Storb, MD, Ted A. Gooley, PhD, Brenda M. Sandmaier, MD, Aleksandar Radujkovic, MD, Anthony D. Ho, MD, Peter Dreger, MD, Olaf Penack, MD

Blood (2016) 128 (22): 519.

https://doi.org/10.1182/blood.V128.22.519.519

Published: 2016

Journal Articles

JAK1/2 Inhibition As a Salvage Therapy for Steroid Refractory Acute and Chronic Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients

Pooja Khandelwal, MD, Ashley Teusink-Cross, PharmD, Adam S. Nelson, MBBS, Christopher E. Dandoy, MD, Javier A. El-Bietar, MD, Rebecca A Marsh, MD, Ashish R Kumar, MBBS, PhD, Michael S Grimley, MD, Sonata Jodele, MD, Stella M Davies, MBBS, PhD, Kasiani C. Myers, MD

Blood (2016) 128 (22): 4568.

https://doi.org/10.1182/blood.V128.22.4568.4568

Published: 2016

Journal Articles

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Richard McMasters, MD, Brian K. Turpin, DO, Michael J. Absalon, MD, PhD, Christine L. Phillips, MD, Karen Burns, MD, Christopher E. Dandoy, MD, Nihal Bakeer, MBBS, Jun Mo, MD, John Perentesis, MD, Maureen M. O'Brien, MD

Blood (2013) 122 (21): 4940.

https://doi.org/10.1182/blood.V122.21.4940.4940

Published: 2013

NARROW

Burden and Outcomes of Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections (MBI-LCBI) in the First 100 Days after Allogeneic Stem Cell Transplant: A CIBMTR Analysis

Transplant Associated Thrombotic Microangiopathy in Individuals with Fanconi Anemia

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

JAK1/2 Inhibition As a Salvage Therapy for Steroid Refractory Acute and Chronic Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Burden and Outcomes of Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections (MBI-LCBI) in the First 100 Days after Allogeneic Stem Cell Transplant: A CIBMTR Analysis

Transplant Associated Thrombotic Microangiopathy in Individuals with Fanconi Anemia

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

JAK1/2 Inhibition As a Salvage Therapy for Steroid Refractory Acute and Chronic Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only